FDA Warns of Coffee Recall After Analysis Finds Risky Pharmaceutical Drugs


Coffee product marketed as offering suspected weight loss and anxiety relief benefits recalled after testing positive for two pharmaceutical drugs, one of which was taken off the market by the FDA ago has been around for years due to its various health risks. The Food and Drug Administration notes that the presence of these two chemicals makes it an unapproved drug.

The recall comes from Dash Xclusive, which is recalling all of its Imperia Elita Vitaccicco coffees after an FDA analysis found two undeclared compounds: sibutramine, a formerly FDA-approved appetite suppressant, and fluoxetine, an approved drug by the FDA and prescribed for certain mental health conditions. . Both compounds pose potentially serious health risks.

Both of these compounds are risky, especially if you don’t know you are consuming them. According to the FDA, approval of sibutramine was withdrawn after many health risks became apparent, including heart failure and stroke. Fluoxetine, on the other hand, is approved for use with conditions such as panic disorder, OCD, depression, and bulimia.

This latter medicine also comes with a warning that it may cause suicidal thoughts and behavior, requiring close monitoring by the prescribing doctor. The drug can also cause reactions such as high mood, low sodium levels, abnormal bleeding, high serotonin levels, etc.

The recalled Vitaccino coffee was sold online across the United States; the company, which informs its customers on eBay, says it has not received any reports of adverse events related to the recalled product. Customers are advised to stop using coffee and contact their doctor if they have had any health problems that may be caused by coffee.


Comments are closed.